Overview

Study of Ezetimibe and Fenofibrate in Patients With Mixed Hyperlipidemia (0653-036)(COMPLETED)

Status:
Completed
Trial end date:
2004-11-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to assess the cholesterol lowering safety and effectiveness of two investigational drugs in patients with mixed hyperlipidemia (high cholesterol and high triglycerides).
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Ezetimibe
Fenofibrate
Criteria
Inclusion Criteria:

- High cholesterol and high triglycerides

Exclusion Criteria:

- Patient has a condition which, in the opinion of the investigator, might pose a risk
to the patient, interfere with participation in the study, or does not meet the
additional criteria as required by the study